Volume 18 - Issue 12 - December 2005
Right now, many senior residents and fellows are facing the next step in their career, namely joining a practice. The idea of getting paid more than what they have received for the past few years along with working in a practice brings them a sense of excitement and foreboding.
After the interview process and mutual acceptance by each party, the discussion eventually turns to the topic of partnership. The owners only want to hire someone who will become an owner of the practice and will eventually buy them out. The owners explained in great detail the pro
Continuing Education »
Surgical recommendations are sparse when evaluating treatment options for the athletic population diagnosed with hallux limitus, hallux rigidus or first metatarsophalangeal (MPJ) osteoarthritis. However, we have found success in treating athletes with first MPJ arthrodesis, and helping them to achieve pain relief and a return to activities.
Several surgeons have found similar success as evidenced by a review of the literature on this subject. In 1996, Bouche, et. al., advocated first MPJ arthrodesis in active patients, reporting that it could “relieve
Editor's Perspective »
Despite the increased awareness of diabetes in recent years and its potentially devastating complications, the recent report from the Centers for Disease Control and Prevention (CDC) offers a grim portrait of the effort to curtail and prevent the condition. In the last two years alone, there has been a 14 percent increase in the prevalence of diabetes in the United States (see page 8, “News And Trends”).
The estimated number of Americans with diabetes now stands at 20.8 million people in the United States, a 2.6 million increase from 2003. The CDC es
Two years ago, I finished a 10-year period as a member of my state podiatric medical licensing board. During that period, I frequently wondered what a podiatrist must feel when he or she receives a registered letter with a notification of a complaint to the board.
Complaints against DPMs came from a variety of sources. Most were from disgruntled patients. Some came from other DPMs, especially when a partnership between two podiatrists breaks up. Some came from the board of pharmacy when a DPM was perceived to be over-prescribing narcotics or possibly Via
News and Trends »
The prevalence of diabetes in the United States has increased by 14 percent in the last two years, according to a recent report by the Centers for Disease Control and Prevention (CDC). The report concludes that 20.8 million people in the U.S., 7 percent of the population, have the disease and 6.2 million of these people are undiagnosed. In 2003, an estimated 18.2 million people had diabetes, according to the CDC.
Why the rapid rise in diabetes prevalence in just two years? The overall incidence of diabetes may be increasing due to declining diets and sed
Diabetes Watch »
Many exciting antibiotics have either recently been approved, received a new FDA indication or will soon become available. Some are well known and have already been incorporated into clinical practice. Many are the first in their respective classes and have novel mechanisms of action. What place, if any, do these drugs have in the treatment of diabetic foot infections (DFIs)?
That said, let us take a look at a number of newer as well as time-tested antibiotics and assess their efficacy for DFIs.
• Linezolid (Zyvox, Pfizer) and q
- « Previous
- | Page 1 of 3 |
- Next »